Putting the SHAPES pilot project into action
Interview and article by Christine Clark Dr Maureen Spargo and Dr Nicola Goodfellow describe how SHAPES, a pan-European digital healthcare project is being put into action in Northern… read more.
Interview and article by Christine Clark Dr Maureen Spargo and Dr Nicola Goodfellow describe how SHAPES, a pan-European digital healthcare project is being put into action in Northern… read more.
AstraZeneca’s COVID-19 vaccine has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunisation to prevent COVID-19 in individuals 18 years of age… read more.
Article written by Bruve Sylvester Covid-19 patients treated with preventive blood thinning drugs (prophylactic anticoagulants) within 24 hours of admission to hospital have lower subsequent mortality than covid-19… read more.
Article written by Bruce Sylvester Researchers report that ivabradine, a drug used for heart failure, appears to improve symptoms of postural orthostatic tachycardia syndrome, also known as POTS.
Sinovac Biotech has announced phase III results of CoronaVac in COVID-19 treatment.
Article written by Bruce Sylvester Colchicine, a gout treatment, appears to reduce the need for oxygen therapy in COVID-19 patients, researchers reported on Feb. 4, 2021 in the… read more.
Interview and article by Christine Clark. Ivermectin is a good treatment to use interim to and complementary to immunisations, according to Dr David Scheim, one of the authors… read more.
In an analysis, submitted as a pre-print prior to peer-review publication, a two-dose regimen of the ChAdOx1 nCoV-19 vaccine provides minimal protection against mild-moderate COVID-19 infection from the… read more.
Interview and article by Christine Clark. Dr David Scheim, one of the authors of a recent study in Peru, describes the doses of ivermectin that were used and… read more.
Sudden cardiac arrest is more often fatal in people with COVID-19, a new study shows. Those responsible for the research see the results as a wake-up call for… read more.
Interview and article by Christine Clark. Mature, real world data on systematic mass treatment of covid-19 with ivermectin show a sharp fall in excess deaths. IMI interviewed Dr… read more.
ViiV Healthcare, owned by GlaxoSmithKline, announced the European Marketing Authorisation of Rukobia (fostemsavir) 600mg extended-release tablets..
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.